Abstract
Differentiation between progression of disease (POD) and treatment-related changes (TRCs) in brain tumors remains challenging. Both POD and TRCs can lead to mass effects, perilesional edema, and contrast enhancement in conventional MRI, which presents a major problem in clinical decision-making ([1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have